Ionis Pharmaceuticals Drops Another After Phase 3 Setback
Ionis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
Real-world success stories illustrate how households adapt Zero Based Budgeting to save more and reduce waste.
17,559 articlesIonis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
Mortgage lenders are moving AI from experimentation to enterprise deployment in 2026. Addy AI's Michael Vandi explain...
A practical, scenario-driven look at predicting where SpaceX headed by 2026 and how investors can approach this high-...
AMD signals a shift from pure CPUs to AI acceleration, blending edge and cloud compute. This article breaks down what...
BYD’s Q2 2026 results set a new pace for electric vehicles, with a headline figure of 557,090 BEVs. This shift challe...
SPDR S&P Pharmaceuticals ETF has delivered a standout one-year run, yet the longer five-year view casts a shadow. The...
From a brutal 1995 fundraising sprint to a $2+ trillion market cap today, Amazon's origin story centers on relentless...
VOOG surged in a blistering rally before facing headwinds as rates climbed and big tech leadership shifted. Here's wh...
A new moisture-absorbing paint-and-primer system backed by large homebuilders is entering the market, promising to re...
The Ethereum Foundation has begun staking a portion of its treasury, deploying 2,016 ETH as part of a broader move in...
Synopsys topped earnings and revenue expectations as AI-fueled chip design demand remains strong. Yet softer Q2 guida...
Unlock a practical, investor-friendly view of arbor realty (abr) earnings. Learn what drives ABR earnings, how to int...